Abstract
Objective: Neurofibromatosis type 1 (NF1) is the most common hereditary neurocutaneous syndrome. The most crucial morbidity of
NF1 is tumors that may develop. Cases with café-au-lait macules (CALMs) which is the first clinical finding of NF1, due to the anxiety
of its associated morbidity, are referred to the pediatric oncology clinic. In this study, we aimed to examine the characteristics of the
patients who applied to our outpatient clinic with CALMs.
Patients and Methods: The data of 157 pediatric patients who applied to our institution with the diagnosis of CALMs between June
2010 and November 2020 were analyzed retrospectively.
Results: There were 157 pediatric cases referred to us for CALMs. According to the National Institutes of Health (NIH) diagnostic
criteria, 109 (69.4%) cases were diagnosed with NF1. The diagnosis of 22 cases with NF1 were supported by genetic examination.
Optic glioma was detected in 39 (24.8%) cases. In 15 (38.4%) of cases with optic glioma, visual functions were also affected. Second
diagnostic criterion did not develop during the follow-up period, except for macules, in 48 cases (30.5%).
Conclusion: In cases with multiple CALMs, the probability of NF1 diagnosis is high, and close and regular follow-up is of great
importance in catching the development of the second clinical criterion and minimizing its morbidity.
Reference21 articles.
1. [1] Alper JC, Holmes LB. The incidence and significance of
birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol
1983;1:58-68. doi: 10.1111/j.1525-1470. 1983. tb01093.x
2. [2] Whitehouse D. Diagnostic value of the cafe-au-lait spot
in children. Arch Dis Child 1966; 41:316-9. doi: 10.1136/
adc.41.217.316
3. [3] Friedman J M, Gutmann D H, MacCollin M, et al.
Neurofibromatosis: phenotype,natural history, and
pathogenesis . 3. Edition. Baltimore: Johns Hopkins University
Press, 1999.
4. [4] Rosenbaum T, Wimmer K. Neurofibromatosis Type 1 and
associated tumors. Klin Paditr 2014; 226: 309-15 doi: 10.1055/
s-0034.138.2021
5. [5] Ferner RE, Huson SM, Thomas N, et al. Guidelines
for the diagnosis and management of individuals with
neurofibromatosis 1. J Med Genet 2007; 44: 81-8. doi: 10.1136/
jmg.2006.045906